Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Cardiac Arrhythmia Market, Global Forecast by Segment, Region (North America, Latin America, Europe, Asia Pacific and Rest of the World), End-User, & Key Players" report has been added to ResearchAndMarkets.com's offering.
Global Cardiac Arrhythmia Market will be US$ 7.9 Billion by 2026.
Globally, cardiovascular diseases are the leading cause of mortality. According to the World Health Organisation, nearly 17.9 million global deaths occur due to cardiovascular disease every year. According to the American Heart Association (AHA), more than 800 thousand individuals die from cardiovascular diseases in the United States each year and nearly 92.1 million Americans are living with some form of cardiovascular disease. A cardiac arrhythmia is a condition where the person heartbeat is irregular, i.e., either, too slow, or too fast. Cardiac arrhythmia monitoring devices help in monitoring the patients who are at risk with heart arrhythmia.
What is Cardiac Arrhythmia and How Monitoring Device Helps?
People with cardiovascular diseases have increased risk of cardiac arrhythmia conditions like tachycardia and bradycardia that need continuous monitoring to overcome sudden heart failure. When a heart rate is above 100 beats per minute in adults that it is called "tachycardia". And when the heart rate of an adult is below 60 beats per minute than it is called "bradycardia".
The cardiac arrhythmia monitoring device can monitor or record the electrical activity of the heart. These devices help in identifying the type and the cause of irregular heart rhythms. These devices help to continuously monitor the patients suffering from cardiac arrhythmia through remote patient monitoring.
Factors Driving the Cardiac Arrhythmia Market
The growth of telemedicine and the popularity of smartphone technology has changed the landscape of cardiac monitoring devices. In addition, key players operating in the market are competing based on advanced and connected cardiac arrhythmia monitoring devices which is expected to propel the growth of this market in upcoming years.
The driving force, which is boosting the global cardiac arrhythmia market, is surging cases of lifestyle habits like obesity, smoking and excessive alcohol consumption. Some other factors include rising healthcare expenditure, rising consumption of tobacco and alcohol, accelerating economic growth, growing obese population.
All the key players have been covered from 3 Viewpoints
- Overview
- Recent Developments
- Revenue Analysis
Key Players
- Abbott Laboratories
- GE Healthcare
- Medtronic PLC
- Koninklijke Philips NV
- Biotelemetry, Inc.
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Cardiac Arrhythmia Monitoring Devices Market
6. Market Share
6.1 By Segment
6.2 By End-User
6.3 By Region
7. Market by Segment
7.1 Implantable Cardiac Monitoring Devices
7.1.1 Market Trend
7.1.2 Market Forecast
7.2 ECG Testing Device
7.2.1 Market Trend
7.2.2 Market Forecast
7.3 Mobile Cardiac Telemetry Monitors
7.3.1 Market Trend
7.3.2 Market Forecast
7.4 Event Recorder
7.4.1 Market Trend
7.4.2 Market Forecast
8. Market by Region
8.1 North America
8.1.1 United States
8.1.2 Canada
8.2 Latin America
8.3 Europe
8.4 Asia-Pacific (APAC)
8.5 Rest of the World
9. Market by End-User
9.1.1 Hospitals, Clinics & Cardiac Centers
9.1.2 Ambulatory Surgery Centers
9.1.3 Other End-User
10. Key Players Analysis
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Recent Developments
10.1.3 Revenue Analysis
10.2 GE Healthcare
10.3 Medtronic PLC
10.4 Koninklijke Philips NV
10.5 Biotelemetry, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/zppj5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.